Skip to main content
Oriola Oyj logo

Oriola Oyj — Investor Relations & Filings

Ticker · OKDAV ISIN · FI0009014344 LEI · 549300UWB1AIR85BM957 HE Wholesale and retail trade
Open in API
Filings indexed 1,782 across all filing types
Latest filing 2026-01-15 AGM Information
Country FI Finland
Listing HE OKDAV

About Oriola Oyj

https://www.oriola.com/

Oriola is a health and wellbeing company providing pharmaceutical distribution, wholesale, and advisory services in the Nordic market. The company connects pharmaceutical companies and health product suppliers with pharmacies, healthcare providers, veterinarians, and retailers. Core services include GDP-compliant supply chain management, warehousing, and specialized logistics like cold chain and vaccine distribution. The wholesale business offers a broad product range and leverages deep market knowledge to facilitate market access. Advisory services support clients throughout the product lifecycle with expertise in market entry, regulatory compliance, and commercial strategy, ensuring operational efficiency and customer value.

Recent filings

Filing Released Lang Actions
01156177.pdf
AGM Information Classification · 98% confidence The document is a stock exchange release from Oriola Corporation detailing the proposals of the Shareholders' Nomination Board regarding the composition and remuneration of the Board of Directors for the upcoming 2026 Annual General Meeting. This type of document is a standard proxy-related disclosure provided to shareholders in advance of the meeting to inform their voting decisions. It fits the definition of Proxy Solicitation & Information Statement (PSI) as it outlines board nominations and compensation proposals to be voted upon.
2026-01-15 English
Proposals of the Shareholders' Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2026 Annual General Meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a stock exchange release from Oriola Corporation detailing the proposals of the Shareholders' Nomination Board regarding the election of the Board of Directors and their remuneration for the upcoming 2026 Annual General Meeting. This type of document, which provides information to shareholders in preparation for a meeting, falls under the category of Proxy Solicitation & Information Statement (PSI), as it outlines board nominations and compensation structures to be voted upon.
2026-01-15 English
01156176.pdf
AGM Information Classification · 98% confidence The document is a stock exchange release from Oriola Oyj detailing the proposals of the Shareholders' Nomination Board regarding the composition and remuneration of the Board of Directors for the upcoming 2026 Annual General Meeting. This type of document is standard preparatory material for an AGM, providing shareholders with information on board candidates and compensation structures before the official meeting notice is issued. It falls under the category of AGM-related information.
2026-01-15 Finnish
Oriolan osakkeenomistajien nimitystoimikunnan ehdotukset varsinaisessa yhtiökokouksessa 2026 valittavasta hallituksesta
AGM Information Classification · 98% confidence The document is a stock exchange release from Oriola Oyj detailing the proposals of the Shareholders' Nomination Committee regarding the composition and remuneration of the Board of Directors for the upcoming 2026 Annual General Meeting. These proposals are standard materials prepared for shareholders in advance of an AGM to inform their voting decisions. While it relates to board composition, it is specifically a pre-meeting proposal document rather than a post-meeting voting result (DVA) or a simple management change announcement (MANG). It fits best under AGM-R as it contains the specific materials and proposals for the AGM agenda.
2026-01-15 Finnish
12198188.pdf
Earnings Release Classification · 95% confidence The document is a stock exchange release issued by Oriola Corporation regarding a specific financial event (an impairment charge related to a joint venture). It is not a full financial report, but rather a standalone announcement of a material financial development. It does not fit into specific categories like M&A, dividends, or director dealings, and it is not a report publication announcement (RPA) as it provides the actual financial impact details rather than just announcing the availability of a report. Therefore, it falls under the general regulatory filing category. Q4 2025
2025-12-19 English
Kronans Apotek to record an impairment with an impact of approximately EUR 16 million to Oriola's net result
Earnings Release Classification · 95% confidence The document is a 'Stock Exchange Release' issued by Oriola Corporation regarding a specific financial event (an impairment charge related to a joint venture). It provides details on the financial impact of this impairment on the company's net result and confirms that the company's outlook remains unchanged. Since it is a specific regulatory announcement regarding a financial event rather than a full report, and it does not fit into the specific categories like M&A or dividend announcements, it is classified as a general regulatory filing. Q4 2025
2025-12-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.